ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

ASSIST Smoking Intervention gets Under Way In 1991

December 1, 1989

In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei

May 22, 1992

Cancer Meetings Listed for Next Three Months

January 19, 1996